Relafen 750, or Relafen, or Naproxcinod, or the medication represents a unique approach within pain relief , viewed through a biochemical pharmacy perspective. A formulation, comprising naproxcinod, attempts to affect cyclooxygenase (COX) activity, specifically COX-2, even demonstrating minimal inhibition of COX-1. As a result , the potential for s